Put Options

23 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $37,814 - $47,360
200 New
200 $38,000
Q3 2023

Nov 14, 2023

SELL
$253.3 - $285.89 $2.36 Million - $2.66 Million
-9,300 Reduced 25.41%
27,300 $7.02 Million
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $10.1 Million - $11.6 Million
36,600 New
36,600 $10.4 Million
Q4 2022

Feb 14, 2023

SELL
$252.44 - $306.72 $7.07 Million - $8.59 Million
-28,000 Reduced 45.16%
34,000 $9.42 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $5.8 Million - $8 Million
29,800 Added 92.55%
62,000 $16.6 Million
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $3.19 Million - $3.79 Million
-17,000 Reduced 34.55%
32,200 $6.57 Million
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $44.3 Million - $55.8 Million
-228,400 Reduced 82.28%
49,200 $10.4 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $18 Million - $23.1 Million
80,300 Added 40.7%
277,600 $66.6 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $21.4 Million - $27.9 Million
75,700 Added 62.25%
197,300 $55.8 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $25 Million - $40.1 Million
96,600 Added 386.4%
121,600 $42.1 Million
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $2.65 Million - $3.1 Million
-10,900 Reduced 30.36%
25,000 $6.99 Million
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $2.39 Million - $3.59 Million
-10,100 Reduced 21.96%
35,900 $8.79 Million
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $1.11 Million - $1.28 Million
-4,200 Reduced 8.37%
46,000 $13 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $3.96 Million - $5.24 Million
15,300 Added 43.84%
50,200 $13.4 Million
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $18.4 Million - $23.4 Million
-68,500 Reduced 66.25%
34,900 $11 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $3.94 Million - $5.44 Million
-17,900 Reduced 14.76%
103,400 $30.7 Million
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $4.5 Million - $5.05 Million
20,700 Added 20.58%
121,300 $28.2 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $17.8 Million - $19.6 Million
81,000 Added 413.27%
100,600 $23.5 Million
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $18.3 Million - $28.6 Million
-84,400 Reduced 81.15%
19,600 $4.63 Million
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $1.5 Million - $1.9 Million
5,400 Added 5.48%
104,000 $31.3 Million
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $9.42 Million - $12.3 Million
32,100 Added 48.27%
98,600 $34.8 Million
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $7.73 Million - $9.21 Million
30,000 Added 82.19%
66,500 $19.3 Million
Q1 2018

May 15, 2018

BUY
$260.13 - $367.91 $9.49 Million - $13.4 Million
36,500 New
36,500 $9.99 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.